Clinical and neurological manifestations in patients with COVID-19 admitted to the Camilo Cienfuegos General Hospital, Sancti Spíritus
Abstract
Introduction: In the world, a significant number of COVID-19 patients with neurological manifestations have been reported, including Cuba and Sancti Spíritus as examples of this situation in its clinical spectrum.
Objective: to analyze the behavior of clinical and neurological manifestations in patients with COVID-19 admitted to the Camilo Cienfuegos Provincial General Hospital of Sancti Spíritus.
Methods: A prospective, observational study was carried out at the institution. The population under study consisted of 480 patients and the intentional non-probabilistic sample was made up of 164 patients with COVID-19 who had neurological manifestations during the study period and met the inclusion and exclusion criteria. The variables used were: age, sex, occupation, associated comorbidities, clinical form of the disease, immunization, symptoms and signs of the disease, complications and status at discharge.
Results: 34.8% were in the group between 40 and 59 years of age, 39.1% were workers; 71.3% were hypertensive and 39.0% suffered from diabetes mellitus. The moderate clinical evolutionary form predominated with 70.7%, headache (71.3%) and vertigo (70.3%) were the most frequent neurological symptoms, the most frequent complications were stroke (6.7%), 95.1% were immunized and of them 65.2% with the Abdala vaccine, 59.8% of the patients were discharged alive.
Conclusions: the largest number of patients were men, workers between 40 and 59 years of age, hypertensive, with headache and vertigo as the most frequent neurological symptoms, few cases with complications, the majority were immunized and survived without sequelae.
DeCS: COVID-19; SIGNS AND SYMPTOMS; NEUROLOGIC MANIFESTATIONS; INPATIENTS; HOSPITALS, STATE.
Downloads
References
1. World Health Organization [Internet]. Geneva: WHO; 2020[updated 2020 Jan 20; cited 2023 feb 3]. Novel Coronavirus (2019-nCoV). Situation Report-1; [about 2 screens]. Available from:
2. National Center for Immunization and Respiratory Diseases (U.S.). Human coronavirus types. Division of Viral Diseases [Internet]. 2020 [cited 2023 Agu 20]. Available from: https://stacks.cdc.gov/view/cdc/84531
3. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun [Internet]. 2020 [cited 2023 May 6]; 109 :102433. Available from: https://pubmed.ncbi.nlm.nih.gov/32113704/
4. Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A; et al. World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19). Int J Surg [Internet]. 2020 [cited 2023 May 6]; 76:71-76 . Available from: https://pubmed.ncbi.nlm.nih.gov/32112977/
5. Chen Y, Liu Q, Guo D. Emerging Coronaviruses: genome structure, replication, and pathogenesis. J Med Virol [Internet]. 2020 [cited 2023 May 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/31967327/
6. Han Q, Lin Q, Jin S, You L. Recent insights into 2019-nCoV: a brief but comprehensive review. J Infect [Internet]. 2020 [cited 2023 May 6]; 4453(20). Available from: https://flutrackers.com/forum/forum/-2019-ncov-new-coronavirus/-2019-ncov-studies-research-academia/832949-j-infect-recent-insights-into-2019-ncov-a-brief-but-comprehensive-review
7. MINSAP. Nota informativa sobre la COVID-19 en Cuba [Internet]. La Habana: Editorial de ciencias médica; 2020. [citado 6 May 2023]. Disponible en: https://temas.sld.cu/coronavirus/category/a
8. De Felice FG, Tovar MF, Moll J, Muñoz DP, Ferreira ST. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. Trends Neurosci [Internet]. 2020 [cited 2023 May 6]; 43(6):355-357. Available from: https://pubmed.ncbi.nlm.nih.gov/32359765/
9. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA [Internet] 2020 [citado 6 May 2023]; 323(13): 1239-1242. Available from: https://pubmed.ncbi.nlm.nih.gov/32091533/
10. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic Features in Severe SARS CoV-2 Infection. N Engl J Med [Infomed]. 2020 [citado 6 May 2023];382(23):2268-2270. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32294339/
11. Gil Rodrigo A, Miró O, Piñera P, Burillo Putze G, Jiménez S, Martín A; et al. Evaluación de las características clínicas y evolución de pacientes con COVID-19 a partir de una serie de 1000 pacientes atendidos en servicios de urgencias españoles. Emergencias [Internet]. 2020 [citado 6 May 2023]; 32:233-41.Disponible en: https://revistaemergencias.org/numeros-anteriores/volumen-32/numero-4/evaluacion-de-las-caracteristicas-clinicas-y-evolucion-de-pacientes-con-covid-19-a-partir-de-una-serie-de-1000-pacientes-atendidos-en-servicios-de-urgencias-espanoles/
12. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang, C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med [Internet]. 2020 [cited 2023 May 6]; 8(4):420-2. Available from: https://pubmed.ncbi.nlm.nih.gov/32085846/
13. Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun [Internet]. 2020 [cited 2023 May 6];88:945-946. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7146652/
14. Martínez Suárez CL, Rivero Chau C. Manifestaciones neurológicas en pacientes positivos al SARS-CoV-2. Univ Méd Pinareña [Internet]. 2022 [citado 6 May 2023]; 18(1):e838. Disponible en: http://revgaleno.sld.cu/index.php/ump/article/view/838
15. Rodríguez Rodríguez E, Gómez Goméz AF. Guía clínica para la atención al paciente long Covid/Covid persistente [Internet]. Madrid: SEMG; 2021 [citado 6 May 2023]. Disponible en:
16. Mena J, Peña S, Polanco S, Rosario J, Ureña S, Villegas F, et al. Evaluación de las manifestaciones neurológicas en pacientes diagnosticados con COVID-19. Una revisión sistemática. Ciencia y Salud [Internet]. 2021 [citado 15 Oct 2021];5(3). Disponible en: https://revistas.intec.edu.do/index.php/cisa/article/view/2306
17. Cepero Pérez I, Conde Cueto T, García Cairo Y, González Fernández Y. Actualización sobre el conocimiento y la comprensión de la COVID 19 en el adulto mayor. Medisur [Internet]. 2021 [citado 2 Feb 2022]; 20(1):[aprox. 137 p.]. Disponible en: http://medisur.sld.cu/index.php/medisur/article/view/5290
18. Sociedad Españ ola de Neurología. Manual COVID-19 para el neurólogo general [Internet] 2020 [citado 2 Feb 2022] Disponible en: http://www.sen.es/attachments/article/2677/Manual_neuroCOVID-19_SEN.pdf
19. Solomon T, Michael BD, Smith PE, Sanderson F, Davies NW, Hart IJ; et al. Management of suspected viral encephalitis in adults-Association of British Neurologists and British Infection Association National Guidelines. J Infect [Internet]. 2012 [cited 2023 Ene 31];64(4):347-373. Available from: https://pubmed.ncbi.nlm.nih.gov/22120595/
20. Benítez-Martínez M, Revueltas-Agüero M. Aspectos relacionados con las vacunas contra la Covid-19 en el mundo y en Cuba. Noviembre 2022. Rev haban cienc méd [Internet]. 2022 [citado 31 Ene 2023]; 21(5): e5079. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/5079
21. Mathieu E, Ritchie H, Rodés Guirao L, Appel C, Giattino C, Hasell J, et al. Coronavirus Pandemic (COVID-19) [Internet]. London: Ourworldindata; 2022 [citado 29 Oct 2023]. Available from: https://ourworldindata.org/coronavirus
22. Uribe-Jaimes PD, Guraieb-Chahin P, Gandarilla-Martínez NA, García-Santos RA, Treviño-Frenk I, Del Río-Quiñones MA; et al. Manifestaciones neurológicas en pacientes hospitalizados con SARS-CoV-2: una cohorte mexicana. An Med ABC [Internet]. 2022[citado 29 Oct 2023];67(4):271-277. Disponible en: https://www.medigraphic.com/pdfs/abc/bc-2022/bc224e.pdf
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Yuniel Abreu-Hernández, Daimara Barrera-Leon, Yamil Fidel García-Guevara, yaneisy Valdez–Gutiérrez, Jorge Luis Lorente Montiel
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/
22 julio 2025